Durbin Scott 4
4 · VIVEVE MEDICAL, INC. · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Durbin Scott
Chief Financial Officer
Transactions
- Award
Common Stock
2019-01-29+62,250→ 73,818 total
Footnotes (1)
- [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 62,250 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States.